Dexamethasone exposure and asparaginase antibodies affect relapse risk in acute lymphoblastic leukemia

We have previously hypothesized that higher systemic exposure to asparaginase may cause increased exposure to dexamethasone, both critical chemotherapeutic agents for acute lymphoblastic leukemia. Whether interpatient pharmaco-kinetic differences in dexamethasone contribute to relapse risk has never...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Kawedia, Jitesh D., Liu, Chengcheng, Pei, Deqing, Cheng, Cheng, Fernandez, Christian A., Howard, Scott C., Campana, Dario, Panetta, John C., Bowman, W. Paul, Evans, William E., Pui, Ching-Hon, Relling, Mary V.
Format: Artigo
Langue:Inglês
Publié: American Society of Hematology 2012
Sujets:
Clinical Trials and Observations
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3286344/
https://ncbi.nlm.nih.gov/pubmed/22117041
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2011-09-381731
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires